BIOLOGY OF FLT3 LIGAND AND RECEPTOR

被引:0
|
作者
LYMAN, SD
机构
关键词
FLT3; LIGAND; STEM CELLS; TYROSINE KINASE RECEPTORS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The flt3 ligand is a member of a small family of growth factors that stimulate the proliferation of hematopoietic cells; other members of this family include Steel factor (also known as mast cell growth factor, stem cell factor, and kit ligand) and colony stimulating factor 1. These proteins function by binding to and activating unique tyrosine kinase receptors. Expression of the flt3 receptor is primarily restricted among hematopoietic cells to the most primitive progenitor cells. The flt3 ligand is similar to Steel factor in that both proteins stimulate the proliferation of early progenitor or stem cells. Neither of these factors has much proliferative activity on its own, but each factor can synergize with a wide range of other colony stimulating factors and interleukins (ILs) to stimulate proliferation. One major difference between the two factors appears to be their effect on mast cells, which Steel factor stimulates but flt3 ligand does not. Although flt3 ligand and Steel factor each act on early hematopoietic cells, differences in their activities suggest that they are not redundant and both are required for normal hematopoiesis. There are a number of clinical settings in which the flt3 ligand may potentially prove quite useful.
引用
收藏
页码:63 / 73
页数:11
相关论文
共 50 条
  • [1] FLT3: Receptor and ligand
    Drexler, HG
    Quentmeier, H
    GROWTH FACTORS, 2004, 22 (02) : 71 - 73
  • [2] FLT3: Receptor and ligand. Biology and potential clinical application
    Shurin, MR
    Esche, C
    Lotze, MT
    CYTOKINE & GROWTH FACTOR REVIEWS, 1998, 9 (01) : 37 - 48
  • [3] Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells
    Drexler, HG
    LEUKEMIA, 1996, 10 (04) : 588 - 599
  • [4] Further activation of FLT3 mutants by FLT3 ligand
    R Zheng
    E Bailey
    B Nguyen
    X Yang
    O Piloto
    M Levis
    D Small
    Oncogene, 2011, 30 : 4004 - 4014
  • [5] Further activation of FLT3 mutants by FLT3 ligand
    Zheng, R.
    Bailey, E.
    Nguyen, B.
    Yang, X.
    Piloto, O.
    Levis, M.
    Small, D.
    ONCOGENE, 2011, 30 (38) : 4004 - 4014
  • [6] MECHANISM OF FLT3 LIGAND DEPENDENT RESISTANCE TO FLT3 INHIBITORS
    Chen, Fangli
    Ishikawa, Yuichi
    Kihara, Rika
    Naoe, Tomoki
    Kiyoi, Hitoshi
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (09) : S57 - S57
  • [7] Expression of the flt3 receptor and responses to the flt3 ligand by human dermal microvascular endothelial cells.
    Chen, H
    Zhang, X
    Karasek, M
    FASEB JOURNAL, 1998, 12 (04): : A450 - A450
  • [8] Mechanism of FLT3 Ligand Dependent Resistance to FLT3 Inhibitors
    Chen, Fangli
    Ishikawa, Yuichi
    Kiyoi, Hitoshi
    Naoe, Tomoki
    BLOOD, 2014, 124 (21)
  • [9] FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo
    Sato, Takashi
    Yang, Xiaochuan
    Knapper, Steven
    White, Paul
    Smith, B. Douglas
    Galkin, Steven
    Small, Donald
    Burnett, Alan
    Levis, Mark
    BLOOD, 2011, 117 (12) : 3286 - 3293
  • [10] FLT3 mutant activation is still dependent on FLT3 ligand.
    Zheng, R
    Piloto, O
    Small, D
    BLOOD, 2005, 106 (11) : 646A - 646A